On Saturday, September 13, the New England Sickle Cell Consortium (NESCC), in partnership with Smilow Cancer Hospital and Yale Cancer Center, hosted its annual Sickle Cell Symposium in New Haven.
The event brought together patients, family members, clinicians, researchers, and advocates with a shared commitment to improving care and advancing research for individuals living with sickle cell disease.
During the first half of the day, attendees had the opportunity to learn about the latest advancements in brain health, neurocognition, and chronic management of sickle cell disease. The symposium also highlighted the experiences of patients and families who shared their stories of living with sickle cell disease. Cece Calhoun, MD, MPH, MBA, assistant professor of medicine (hematology) and medical director of the Adult Sickle Cell Program at Smilow Cancer Hospital, opened the event and Layla Van Doren, MD, MBA, assistant professor of medicine (hematology) was the emcee for the day.
“We were honored to have distinguished speakers and panelists from across New England, each bringing their expertise and passion to this important field,” says Van Doren. “The conversations and collaborations are essential to our mission of building stronger networks of care, accelerating research, and influencing policy to improve the lives of all individuals affected by sickle cell disease. We extend our heartfelt thanks to everyone who joined us on this special day. Together, we are shaping a brighter future for those living with sickle cell disease.”
The day wrapped up with a lively “Sickle Cell-abration” in Amistad Park where guests came together to enjoy dancing, food, face painting, and connect with several community organizations in attendance.